Home
About
FAQ
History (5)
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models.
Principal Investigator
Resection of the scaphoid distal pole for symptomatic scaphoid nonunion after failed previous surgical treatment.
Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Biography
contributor
Principal Investigator
Time
start date
2019-09-01
end date
2023-08-31
